title: Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients.
authors.affiliation: Medizinische Klinik und Poliklinik V, Universität Heidelberg, Hospitalstrasse 3, 69115 Heidelberg, Germany. hartmut_goldschmidt@med.uni-heidelberg.de
authors.forename: H
authors.initials: H
authors.lastname: Goldschmidt
authors.forename: P
authors.initials: P
authors.lastname: Sonneveld
authors.forename: F W
authors.initials: FW
authors.lastname: Cremer
authors.forename: B
authors.initials: B
authors.lastname: van der Holt
authors.forename: P
authors.initials: P
authors.lastname: Westveer
authors.forename: I
authors.initials: I
authors.lastname: Breitkreutz
authors.forename: A
authors.initials: A
authors.lastname: Benner
authors.forename: A
authors.initials: A
authors.lastname: Glasmacher
authors.forename: I G D
authors.initials: IG
authors.lastname: Schmidt-Wolf
authors.forename: H
authors.initials: H
authors.lastname: Martin
authors.forename: D
authors.initials: D
authors.lastname: Hoelzer
authors.forename: A D
authors.initials: AD
authors.lastname: Ho
authors.forename: H M
authors.initials: HM
authors.lastname: Lokhorst
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003907:Dexamethasone / Q000008:administration & dosage; D018572:Disease-Free Survival; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D006801:Humans; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D011446:Prospective Studies; D033581:Stem Cell Transplantation; D013792:Thalidomide / Q000008:administration & dosage*
chemical_list: D013792:Thalidomide; D003907:Dexamethasone; D004317:Doxorubicin